Breast Cancer,HER2- Cardiac Impact: Trastuzumab Emtansine vs Paclitaxel+Trastuzumab for HER2+ Breast Cancer Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer NCI-MATCH Phase II: Tolerable TRAEs from Vismdegib Oral Intake Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 eNRGy Study: Zenocutuzumab for NRG1+ Cancers Assessment Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 Study: Rucaparib-resistant BRCA/PALB2 Pancreatic Cancer Treatment Mar 27, 2023
